Cite
HARVARD Citation
Chen, Y. et al. (2018). Saxagliptin add‐on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double‐blind, placebo‐controlled trial. Diabetes, obesity & metabolism. 20 (4), pp. 1044-1049. [Online].